Table 2

Event rate and time to alert by population group

All patientsMynx
(N=109,857) (%)
Alternate device
(N=109,857) (%)
Relative risk (95% CI)Time to alertImprovement in time to alert
Vascular complications1.200.731.63 (1.50 to 1.79)15 months12 months
Access-site bleeding0.370.261.43 (1.23 to 1.67)21 months27 months
Blood transfusion1.731.451.19 (1.12 to 1.28)24 months9 months
Age >70Mynx
(N=40,617) (%)
Alternate device
(N=40,616) (%)
Relative risk (95% CI)Time to alertImprovement in time to alert
Vascular complications1.590.901.77 (1.55 to 2.01)15 months12 months
Access-site bleeding0.530.301.76 (1.41 to 2.20)15 months18 months
Blood transfusion2.642.091.29 (1.16 to 1.39)9 months36 months
FemaleMynx
(N=37,488) (%)
Alternate device
(N=37,488) (%)
Relative risk (95% CI)Time to alertImprovement in time to alert
Vascular complications2.141.221.75 (1.56 to 1.96)12 months15 months
Access-site bleeding0.680.411.67 (1.37 to 2.04)21 months12 months
Blood transfusion3.042.271.33 (1.22 to 1.46)24 months9 months
DiabetesMynx
(N=42,977) (%)
Alternate device
(n=42,976) (%)
Relative risk (95% CI)Time to alertImprovement in time to alert
Vascular complications1.030.641.61 (1.38 to 1.86)21 months6 months
Access-site bleeding0.310.261.23 (0.95 to 1.58)21 months21 months
Blood transfusion2.071.711.21 (1.10 to 1.33)24 months18 months